Top in endocrinology: Cardiovascular risk in menopause; impact of vitamin D on diabetes
Click Here to Manage Email Alerts
The top story in endocrinology last week was about a study investigating cardiovascular risks in menopausal vs. premenopausal women.
Researchers reported that menopausal women tended to have worse cardiovascular risk profiles; however, increases in cardiovascular risk factors were associated with increasing age rather than reproductive stage.
Another top story was about new research on the vitamin D analog eldecalcitol and its effect on patients with prediabetes. According to the study, eldecalcitol did not prevent the development of type 2 diabetes in this population.
Read these and more top stories in endocrinology below:
Women’s CV risk increases with age, not reproductive stage
Menopausal women tend to have worse cardiovascular risk profiles than premenopausal women, but 5-year increases in cardiovascular risk factors are not dependent on reproductive stage, according to data from the CoLaus study. Read more.
Vitamin D analog does not affect incidence rates of type 2 diabetes in adults
Eldecalcitol, a vitamin D analog, is not associated with a reduced incidence of type 2 diabetes among adults with prediabetes, though it may have a beneficial effect in those with lower insulin secretion, according to study data. Read more.
Bariatric surgery improves diabetes remission, reduces cardiometabolic risk
Compared with conventional treatment, bariatric surgery was superior in achieving remission of prediabetes and type 2 diabetes and reducing cardiometabolic risks for patients with obesity, researchers reported in Obesity Medicine. Read more.
Low-dose ADHD drugs do not affect thyroid function, growth hormone at 1 year
Among children diagnosed with ADHD, low doses of ADHD medications did not affect thyroid or growth hormone levels, according to study data. Read more.
Genetic risk, low diet quality increase type 2 diabetes risk
Genetic risk and poorer diet quality each independently increase the risk for developing type 2 diabetes, according to study data. Read more.